FUS-mediated alternative splicing in the nervous system: consequences for ALS and FTLD (original) (raw)

References

1. Kwiatkowski TJ, Bosco DA, LeClerc AL, Tamrazian E, Vanderburg CR, Russ C, Davis A, Gilchrist J, Kasarskis EJ, Munsat T et al (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323:1205–1208
   Article CAS PubMed Google Scholar
2. Vance C, Rogelj B, Hortobágyi T, De Vos KJ, Nishimura AL, Sreedharan J, Hu X, Smith B, Ruddy D, Wright P et al (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323:1208–1211
   Article CAS PubMed Google Scholar
3. Neumann M, Rademakers R, Roeber S, Baker M, Kretzschmar HA, Mackenzie IR (2009) A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 132:2922–2931
   Article PubMed Google Scholar
4. Pasinelli P, Brown RH (2006) Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci 7:710–723
   Article CAS PubMed Google Scholar
5. Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR, Zoing MC (2011) Amyotrophic lateral sclerosis. Lancet 377:942–955
   Article CAS PubMed Google Scholar
6. Bird T, Knopman D, VanSwieten J, Rosso S, Feldman H, Tanabe H, Graff-Raford N, Geschwind D, Verpillat P, Hutton M (2003) Epidemiology and genetics of frontotemporal dementia/Pick's disease. Ann Neurol 54:S29–S31
   Article PubMed Google Scholar
7. Thomas M, Alegre-Abarrategui J, Wade-Martins R (2013) RNA dysfunction and aggrephagy at the centre of an amyotrophic lateral sclerosis/frontotemporal dementia disease continuum. Brain 136(Pt 5):1345–1360
   Article PubMed Google Scholar
8. Mackenzie IRA, Rademakers R, Neumann M (2010) TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol 9:995–1007
   Article CAS PubMed Google Scholar
9. Rademakers R, Neumann M, Mackenzie IR (2012) Advances in understanding the molecular basis of frontotemporal dementia. Nat Rev Neurol 8:423–434
   CAS PubMed Google Scholar
10. Josephs KA, Hodges JR, Snowden JS, Mackenzie IR, Neumann M, Mann DM, Dickson DW (2011) Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol 122:137–153
    Article PubMed Google Scholar
11. Dormann D, Haass C (2013) Fused in sarcoma (FUS): an oncogene goes awry in neurodegeneration. Mol Cell Neurosci. doi:10.1016/j.mcn.2013.03.006
    PubMed Google Scholar
12. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A et al (1998) Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393:702–705
    Article CAS PubMed Google Scholar
13. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130–133
    Article CAS PubMed Google Scholar
14. Neumann M, Bentmann E, Dormann D, Jawaid A, DeJesus-Hernandez M, Ansorge O, Roeber S, Kretzschmar HA, Munoz DG, Kusaka H et al (2011) FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations. Brain 134:2595–2609
    Article PubMed Google Scholar
15. Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, Pirici D, Rademakers R, Vandenberghe R, Dermaut B, Martin JJ et al (2006) Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 442:920–924
    Article CAS PubMed Google Scholar
16. Renton AE, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L et al (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72:257–268
    Article CAS PubMed Google Scholar
17. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NiCole A, Flynn H et al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72:245–256
    Article CAS PubMed Google Scholar
18. Gijselinck I, Van Langenhove T, van der Zee J, Sleegers K, Philtjens S, Kleinberger G, Janssens J, Bettens K, Van Cauwenberghe C, Pereson S et al (2012) A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol 11:54–65
    Article CAS PubMed Google Scholar
19. Åman P, Panagopoulos I, Lassen C, Fioretos T, Mencinger M, Toresson H, Höglund M, Forster A, Rabbitts TH, Ron D et al (1996) Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS. Genomics 37:1–8
    Article PubMed Google Scholar
20. Zinszner H, Sok J, Immanuel D, Yin Y, Ron D (1997) TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. J Cell Sci 110:1741–1750
    CAS PubMed Google Scholar
21. Dormann D, Rodde R, Edbauer D, Bentmann E, Fischer I, Hruscha A, Than ME, Mackenzie IRA, Capell A, Schmid B et al (2010) ALS-associated fused in sarcoma (FUS) mutations disrupt transportin-mediated nuclear import. EMBO J 29:2841–2857
    Article CAS PubMed Google Scholar
22. Kato M, Han Tina W, Xie S, Shi K, Du X, Wu Leeju C, Mirzaei H, Goldsmith EJ, Longgood J, Pei J et al (2012) Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels. Cell 149:753–767
    Article CAS PubMed Google Scholar
23. Hoell JI, Larsson E, Runge S, Nusbaum JD, Duggimpudi S, Farazi TA, Hafner M, Borkhardt A, Sander C, Tuschl T (2011) RNA targets of wild-type and mutant FET family proteins. Nat Struct Mol Biol 18:1428–1431
    Article CAS PubMed Google Scholar
24. Hicks GG, Singh N, Nashabi A, Mai S, Bozek G, Klewes L, Arapovic D, White EK, Koury MJ, Oltz EM et al (2000) Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death. Nat Genet 24:175–179
    Article CAS PubMed Google Scholar
25. Kuroda M, Sok J, Webb L, Baechtold H, Urano F, Yin Y, Chung P, de Rooij DG, Akhmedov A, Ashley T et al (2000) Male sterility and enhanced radiation sensitivity in TLS(−/−) mice. EMBO J 19:453–462
    Article CAS PubMed Google Scholar
26. Fujii R, Okabe S, Urushido T, Inoue K, Yoshimura A, Tachibana T, Nishikawa T, Hicks GG, Takumi T (2005) The RNA binding protein TLS is translocated to dendritic spines by mGluR5 activation and regulates spine morphology. Curr Biol CB 15:587–593
    Article CAS Google Scholar
27. Orozco D, Tahirovic S, Rentzsch K, Schwenk BM, Haass C, Edbauer D (2012) Loss of fused in sarcoma (FUS) promotes pathological tau splicing. EMBO Rep 13:759–764
    Article CAS PubMed Google Scholar
28. Mitchell J, McGoldrick P, Vance C, Hortobagyi T, Sreedharan J, Rogelj B, Tudor E, Smith B, Klasen C, Miller CJ et al (2013) Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion. Acta Neuropathol 125(2):273–288
    Article CAS PubMed Google Scholar
29. Lanson NA Jr, Pandey UB (2012) FUS-related proteinopathies: lessons from animal models. Brain Res 1462:44–60
    Article CAS PubMed Google Scholar
30. Licatalosi DD, Darnell RB (2010) RNA processing and its regulation: global insights into biological networks. Nat Rev Genet 11:75–87
    Article CAS PubMed Google Scholar
31. Li Q, Lee J-A, Black DL (2007) Neuronal regulation of alternative pre-mRNA splicing. Nat Rev Neurosci 8:819–831
    Article CAS PubMed Google Scholar
32. Dredge BK, Polydorides AD, Darnell RB (2001) The splice of life: alternative splicing and neurological disease. Nat Rev Neurosci 2:43–50
    Article CAS PubMed Google Scholar
33. Yeo G, Holste D, Kreiman G, Burge C (2004) Variation in alternative splicing across human tissues. Genome Biol 5:R74
    Article PubMed Google Scholar
34. Wahl MC, Will CL, Lührmann R (2009) The spliceosome: design principles of a dynamic RNP machine. Cell 136:701–718
    Article CAS PubMed Google Scholar
35. Ishigaki S, Masuda A, Fujioka Y, Iguchi Y, Katsuno M, Shibata A, Urano F, Sobue G, Ohno K (2012) Position-dependent FUS-RNA interactions regulate alternative splicing events and transcriptions. Sci Rep 2. http://www.nature.com/srep/2012/120724/srep00529/abs/srep00529.html#supplementary-information
36. Rogelj B, Easton LE, Bogu GK, Stanton LW, Rot G, Curk T, Zupan B, Sugimoto Y, Modic M, Haberman N, Tollervey J, Fujii R, Takumi T, Shaw CE, Ule J (2012) Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain. Sci Rep 2. http://www.nature.com/srep/2012/120828/srep00603/abs/srep00603.html#supplementary-information
37. Lagier-Tourenne C, Polymenidou M, Hutt KR, Vu AQ, Baughn M, Huelga SC, Clutario KM, Ling S-C, Liang TY, Mazur C et al (2012) Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat Neurosci 15:1488–1497
    Article CAS PubMed Google Scholar
38. Nakaya TA, Panagiotis M, Manolis C, Alexandra M, Zissimos (2013) FUS regulates genes coding for RNA-binding proteins in neurons by binding to their highly conserved introns. RNA 19(4):498–509
    Article CAS PubMed Google Scholar
39. Meissner M, Lopato S, Gotzmann J, Sauermann G, Barta A (2003) Proto-oncoprotein TLS/FUS is associated to the nuclear matrix and complexed with splicing factors PTB, SRm160, and SR proteins. Exp Cell Res 283:184–195
    Article CAS PubMed Google Scholar
40. Yang L, Embree LJ, Tsai S, Hickstein DD (1998) Oncoprotein TLS interacts with serine-arginine proteins involved in RNA splicing. J Biol Chem 273:27761–27764
    Article CAS PubMed Google Scholar
41. Gerbino V, Carrì MT, Cozzolino M, Achsel T (2013) Mislocalised FUS mutants stall spliceosomal snRNPs in the cytoplasm. Neurobiol Dis 55:120–128
    Article CAS PubMed Google Scholar
42. Braunschweig U, Gueroussov S, Plocik AM, Graveley Brenton R, Blencowe Benjamin J (2013) Dynamic integration of splicing within gene regulatory pathways. Cell 152:1252–1269
    Article CAS PubMed Google Scholar
43. Schwartz JC, Ebmeier CC, Podell ER, Heimiller J, Taatjes DJ, Cech TR (2012) FUS binds the CTD of RNA polymerase II and regulates its phosphorylation at Ser2. Genes Dev 26:2690–2695
    Article CAS PubMed Google Scholar
44. Lerga A, Hallier M, Delva L, Orvain C, Gallais I, Marie J, Moreau-Gachelin F (2001) Identification of an RNA binding specificity for the potential splicing factor TLS. J Biol Chem 276:6807–6816
    Article CAS PubMed Google Scholar
45. Hong M, Zhukareva V, Vogelsberg-Ragaglia V, Wszolek Z, Reed L, Miller BI, Geschwind DH, Bird TD, McKeel D, Goate A et al (1998) Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 282:1914–1917
    Article CAS PubMed Google Scholar
46. Cooper TA, Wan L, Dreyfuss G (2009) RNA and disease. Cell 136:777–793
    Article CAS PubMed Google Scholar
47. Lorson CL, Androphy EJ (1998) The domain encoded by exon 2 of the survival motor neuron protein mediates nucleic acid binding. Hum Mol Genet 7:1269–1275
    Article CAS PubMed Google Scholar
48. Colombrita C, Onesto E, Megiorni F, Pizzuti A, Baralle FE, Buratti E, Silani V, Ratti A (2012) TDP-43 and FUS RNA-binding proteins bind distinct sets of cytoplasmic messenger RNAs and differently regulate their post-transcriptional fate in motoneuron-like cells. J Biol Chem 287:15635–15647
    Article CAS PubMed Google Scholar
49. Dichmann DS, Harland RM (2012) fus/TLS orchestrates splicing of developmental regulators during gastrulation. Genes Dev 26:1351–1363
    Article CAS PubMed Google Scholar
50. König J, Zarnack K, Luscombe NM, Ule J (2012) Protein–RNA interactions: new genomic technologies and perspectives. Nat Rev Genet 13:77–83
    Article PubMed CAS Google Scholar
51. Buratti E, Romano M, Baralle FE (2013) TDP-43 high throughput screening analyses in neurodegeneration: advantages and pitfalls. Mol Cell Neurosci. doi:10.1016/j.mcn.2013.03.001
    Google Scholar
52. Sephton CF, Cenik C, Kucukural A, Dammer EB, Cenik B, Han Y, Dewey CM, Roth FP, Herz J, Peng J et al (2011) Identification of neuronal RNA targets of TDP-43-containing ribonucleoprotein complexes. J Biol Chem 286:1204–1215
    Article CAS PubMed Google Scholar
53. Tollervey JR, Curk T, Rogelj B, Briese M, Cereda M, Kayikci M, Konig J, Hortobagyi T, Nishimura AL, Zupunski V et al (2011) Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat Neurosci 14:452–458
    Article CAS PubMed Google Scholar
54. Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, Ling S-C, Sun E, Wancewicz E, Mazur C et al (2011) Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci 14:459–468
    Article CAS PubMed Google Scholar
55. Goedert M, Spillantini M (2011) Pathogenesis of the tauopathies. J Mol Neurosci 45:425–431
    Article CAS PubMed Google Scholar
56. Buée L, Bussière T, Buée-Scherrer V, Delacourte A, Hof PR (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Rev 33:95–130
    Article PubMed Google Scholar
57. Lee VM-Y, Goedert M, Trojanowski JQ (2001) Neurodegenerative tauopathies. Annu Rev Neurosci 24:1121–1159
    Article CAS PubMed Google Scholar
58. Panda D, Samuel JC, Massie M, Feinstein SC, Wilson L (2003) Differential regulation of microtubule dynamics by three- and four-repeat tau: implications for the onset of neurodegenerative disease. Proc Natl Acad Sci 100:9548–9553
    Article CAS PubMed Google Scholar
59. Brunden KR, Trojanowski JQ, Lee VMY (2008) Evidence that Non-fibrillar tau causes pathology linked to neurodegeneration and behavioral impairments. J Alzheimers Dis 14:393–399
    PubMed Google Scholar
60. de Calignon A, Fox LM, Pitstick R, Carlson GA, Bacskai BJ, Spires-Jones TL, Hyman BT (2010) Caspase activation precedes and leads to tangles. Nature 464:1201–1204
    Article PubMed CAS Google Scholar
61. Tobin JE, Latourelle JC, Lew MF, Klein C, Suchowersky O, Shill HA, Golbe LI, Mark MH, Growdon JH, Wooten GF et al (2008) Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD study. Neurology 71:28–34
    Article CAS PubMed Google Scholar
62. Caffrey TM, Joachim C, Paracchini S, Esiri MM, Wade-Martins R (2006) Haplotype-specific expression of exon 10 at the human MAPT locus. Hum Mol Genet 15:3529–3537
    Article CAS PubMed Google Scholar
63. Williams-Gray CH, Evans JR, Goris A, Foltynie T, Ban M, Robbins TW, Brayne C, Kolachana BS, Weinberger DR, Sawcer SJ et al (2009) The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain 132:2958–2969
    Article PubMed Google Scholar
64. Skipper L, Wilkes K, Toft M, Baker M, Lincoln S, Hulihan M, Ross OA, Hutton M, Aasly J, Farrer M (2004) Linkage disequilibrium and association of MAPT H1 in Parkinson disease. Am J Hum Genet 75:669–677
    Article CAS PubMed Google Scholar
65. Sundar PD, Yu C-E, Sieh W, Steinbart E, Garruto RM, Oyanagi K, Craig U-K, Bird TD, Wijsman EM, Galasko DR et al (2007) Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia. Hum Mol Genet 16:295–306
    Article CAS PubMed Google Scholar
66. Mawal-Dewan M, Schmidt LM, Balin B, Perl DP, Lee VM-Y, Trojanowski JQ (1996) Identification of phosphorylation sites in PHF-TAU from patients with Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex. J Neuropathol Exp Neurol 55:1051–1059
    CAS PubMed Google Scholar
67. Urwin H, Josephs K, Rohrer J, Mackenzie I, Neumann M, Authier A, Seelaar H, Swieten J, Brown J, Johannsen P et al (2010) FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol 120:33–41
    Article PubMed Google Scholar
68. Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y et al (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351:602–611
    Article CAS PubMed Google Scholar
69. Eastwood SL, Harrison PJ (2007) Decreased mRNA expression of netrin-G1 and netrin-G2 in the temporal lobe in schizophrenia and bipolar disorder. Neuropsychopharmacology 33:933–945
    Article PubMed CAS Google Scholar
70. Yin Y, Miner JH, Sanes JR (2002) Laminets: laminin- and netrin-related genes expressed in distinct neuronal subsets. Mol Cell Neurosci 19:344–358
    Article CAS PubMed Google Scholar
71. Meerabux JMA, Ohba H, Fukasawa M, Suto Y, Aoki-Suzuki M, Nakashiba T, Nishimura S, Itohara S, Yoshikawa T (2005) Human netrin-G1 isoforms show evidence of differential expression. Genomics 86:112–116
    Article CAS PubMed Google Scholar
72. Cirulli V, Yebra M (2007) Netrins: beyond the brain. Nat Rev Mol Cell Biol 8:296–306
    Article CAS PubMed Google Scholar
73. Aoki-Suzuki M, Yamada K, Meerabux J, Iwayama-Shigeno Y, Ohba H, Iwamoto K, Takao H, Toyota T, Suto Y, Nakatani N et al (2005) A family-based association study and gene expression analyses of netrin-G1 and -G2 genes in schizophrenia. Biol Psychiatry 57:382–393
    Article CAS PubMed Google Scholar
74. Lin L, Lesnick TG, Maraganore DM, Isacson O (2009) Axon guidance and synaptic maintenance: preclinical markers for neurodegenerative disease and therapeutics. Trends Neurosci 32:142–149
    Article CAS PubMed Google Scholar
75. Roof DJ, Hayes A, Adamian M, Chishti AH, Li T (1997) Molecular characterization of abLIM, a novel actin-binding and double zinc finger protein. J Cell Biol 138:575–588
    Article CAS PubMed Google Scholar
76. Lundquist EA, Herman RK, Shaw JE, Bargmann CI (1998) UNC-115, a conserved protein with predicted LIM and actin-binding domains, mediates axon guidance in C. Elegans. Neuron 21:385–392
    Article CAS PubMed Google Scholar
77. Erkman L, Yates PA, McLaughlin T, McEvilly RJ, Whisenhunt T, O'Connell SM, Krones AI, Kirby MA, Rapaport DH, Bermingham JR et al (2000) A POU domain transcription factor dependent program regulates axon pathfinding in the vertebrate visual system. Neuron 28:779–792
    Article CAS PubMed Google Scholar
78. Sakurai T (2012) The role of NrCAM in neural development and disorders—beyond a simple glue in the brain. Mol Cell Neurosci 49:351–363
    Article CAS PubMed Google Scholar
79. Wang B, Williams H, Du J-S, Terrett J, Kenwrick S (1998) Alternative splicing of human NrCAM in neural and nonneural tissues. Mol Cell Neurosci 10:287–295
    Article CAS Google Scholar
80. Barnier JV, Papin C, Eychène A, Lecoq O, Calothy G (1995) The mouse B-raf gene encodes multiple protein isoforms with tissue-specific expression. J Biol Chem 270:23381–23389
    Article CAS PubMed Google Scholar
81. Frebel K, Wiese S (2006) Signalling molecules essential for neuronal survival and differentiation. Biochem Soc Trans 34(Pt 6):1287–1290
    CAS PubMed Google Scholar
82. Wiese S, Pei G, Karch C, Troppmair J, Holtmann B, Rapp UR, Sendtner M (2001) Specific function of B-Raf in mediating survival of embryonic motoneurons and sensory neurons. Nat Neurosci 4:137–142
    Article CAS PubMed Google Scholar
83. Zhong J, Li X, McNamee C, Chen AP, Baccarini M, Snider WD (2007) Raf kinase signaling functions in sensory neuron differentiation and axon growth in vivo. Nat Neurosci 10:598–607
    Article CAS PubMed Google Scholar
84. Wu C-H, Fallini C, Ticozzi N, Keagle PJ, Sapp PC, Piotrowska K, Lowe P, Koppers M, McKenna-Yasek D, Baron DM et al (2012) Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature 488:499–503
    Article CAS PubMed Google Scholar
85. Al-Chalabi A, Andersen PM, Nilsson P, Chioza B, Andersson JL, Russ C, Shaw CE, Powell JF, Nigel Leigh P (1999) Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum Mol Genet 8:157–164
    Article CAS PubMed Google Scholar
86. Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, Khan J, Polak MA, Glass JD (2004) Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol 185:232–240
    Article PubMed Google Scholar
87. Saxena S, Caroni P (2011) Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration. Neuron 71:35–48
    Article CAS PubMed Google Scholar
88. Dormann D, Haass C (2011) TDP-43 and FUS: a nuclear affair. Trends Neurosci 34:339–348
    Article CAS PubMed Google Scholar
89. Johnson R (2012) Long non-coding RNAs in Huntington's disease neurodegeneration. Neurobiol Dis 46:245–254
    Article CAS PubMed Google Scholar
90. Suberbielle E, Sanchez PE, Kravitz AV, Wang X, Ho K, Eilertson K, Devidze N, Kreitzer AC, Mucke L (2013) Physiologic brain activity causes DNA double-strand breaks in neurons, with exacerbation by amyloid-β. Nat Neurosci 16:613–621
    Article CAS PubMed Google Scholar
91. Vourekas A, Zheng Q, Alexiou P, Maragkakis M, Kirino Y, Gregory BD, Mourelatos Z (2012) Mili and Miwi target RNA repertoire reveals piRNA biogenesis and function of Miwi in spermiogenesis. Nat Struct Mol Biol 19:773–781
    Article CAS PubMed Google Scholar

Download references